Performance · Recovery · Longevity

Shopping Cart (0)

Catalogue

Shop

Browse “Muscle/Performamnce, Recovery/Tissue, Weight Loss/Metabolic and Research Peptides“ and advanced wellness compounds. Prices are shown in South African Rand (ZAR).

Research peptides & wellness compounds

Select a product to view available quantities, specifications and regulatory status. Quantities, documentation and pricing are confirmed before dispatch.

MOTS-c (UPA Platinum)

Category:
Weight Loss / Metabolic / Longevity
SKU:
TRW-MOTSC
Price:
R 720.00
{{variant.name}}:
{{opt.name}}
{{opt.value ? '' : opt.name}}
{{opt.value ? '' : opt.name}}
Description

TEST RUN WELLNESS MOTS-c 20 | MOTS-c 20mg Self-Mix Vial

 

MOTS-c 20 (MOTS-c 20mg) – Mitochondrial-derived peptide for cellular energy and fat metabolism. Self-mix vial. Advanced metabolic support.

 

Product Overview

MOTS-c 20 is a MOTS-c 20mg self-mix vial. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome rather than nuclear DNA, discovered by researchers at the University of Southern California in 2015.

 

It functions as a mitokine — a hormone-like signal originating in the mitochondria that communicates with distant tissues including muscle, liver, fat tissue, and the brain to coordinate whole-body metabolic responses.

 

How MOTS-c Works: Mitochondrial AMPK Pathway Agonist

MOTS-c activates AMPK (AMP-activated protein kinase), often called the "master metabolic switch," by inhibiting the folate-methionine cycle and causing accumulation of AICAR, a potent AMPK activator.

 

This single mechanism cascades into a remarkable range of metabolic benefits:

· Glucose uptake into muscle cells independent of insulin via GLUT4 translocation

 

· Inhibition of fat synthesis (lipogenesis) and activation of fat burning (beta-oxidation)

 

· Mitochondrial biogenesis — generating more mitochondria for greater energy capacity

 

· Suppression of mTOR — shifting the cell from growth mode to maintenance and repair

In animal studies, MOTS-c restored insulin sensitivity in diet-induced obese mice to near-normal levels without dietary changes and prevented diet-induced obesity.

 

Exercise increases circulating MOTS-c levels, and exogenous MOTS-c has been shown to improve treadmill running capacity in aged mice, earning it the label "exercise mimetic".

 

Body Recomposition Benefits

MOTS-c shifts fuel preference toward fat oxidation by activating AMPK and signalling through the FOXO1 transcription factor, upregulating the enzymes responsible for breaking down fatty acids for fuel. In practical terms, the body burns more fat at rest and during exercise, which is particularly important for individuals in a caloric deficit who want to preserve muscle while losing fat.

 

Research published in Cell Metabolism found that MOTS-c levels naturally decline with age, correlating with metabolic deterioration including reduced insulin sensitivity, decreased exercise capacity, and increased visceral fat accumulation.

 

In a study of breast cancer survivors, increases in MOTS-c levels were associated with reductions in fat mass, body weight, HOMA-IR, CRP, and an increase in lean mass, indicating improved metabolic profiles. A separate study in physically active volunteers found higher serum MOTS-c concentrations positively correlated with greater muscle mass, force, and power generated during jumping exercises.

 

MOTS-c also promotes fat oxidation through AMPK-mediated lipolysis and has been shown to reduce HFD-induced visceral fat and hepatic steatosis, suggesting a potential effect on increasing thermogenic brown and/or beige adipose tissue.

 

Titration Protocol

MOTS-c is typically administered via subcutaneous injection. The standard dosage protocol is 5 to 10 mg per week, run in cycles of 8 to 12 weeks, followed by a 4-week washout period before any repeat cycle.

 

A standard 10-week cycle is as follows:

· Week 1–2 (Ramp-up): 5 mg once weekly — Monday, morning fasted

 

· Week 3–8 (Build/Peak): 5 mg once weekly (beginner) OR 5 mg + 5 mg split (performance) — Monday (and Thursday)

 

· Week 9–10 (Taper): 5 mg once weekly — Monday, morning fasted

 

· Weeks 11–14 (Washout): Off-cycle rest

Beginners should start at 5 mg once per week and assess tolerance for two weeks before increasing. Performance and body recomposition users split 10 mg into two 5 mg doses on non-consecutive days, injecting 30 to 60 minutes before exercise when possible for synergy with training-induced AMPK signaling.

 

Combination Therapy

MOTS-c is commonly stacked with other compounds in wellness and longevity protocols:

· SS-31: Frequently sequenced with MOTS-c for mitochondrial support, with SS-31 often run first followed by MOTS-c

 

· NAD+ precursors: Cycled alongside MOTS-c for mitochondrial biogenesis

 

· 5-Amino-1MQ: Stacked with MOTS-c for metabolic optimization

 

· GLP-1 agonists (e.g., semaglutide, tirzepatide): MOTS-c may complement incretin-based therapies by enhancing metabolic flexibility and mitochondrial function.

 

Community protocols typically run MOTS-c stacks twice per year until benefits plateau. All combination approaches should be pursued under professional medical supervision.

 

Technical Specifications

· Product Name: MOTS-c 20
· Peptide: MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c)
· Concentration: 20mg per vial
· Form: Self-mix vial
· Reconstitution: Requires bacteriostatic water for reconstitution
· Supplier: Test Run Wellness (Wellness.testrun)

 

⚕️ Important Medical Notice

Please consult your medical practitioner regarding your body requirements, as the dosing information provided contains guideline dosages. MOTS-c 20 is intended for use under professional medical supervision.

Regulatory notice. Test Run Wellness is an independent supplier and is not the manufacturer of the products referenced. No product should be used without appropriate regulatory authorisation and professional medical oversight.